CLL disease can be widely heterogeneous, but its fundamental feature is the clonal proliferation of mature, typically CD5+/CD19+/CD23+ B cells accumulating within the BM, blood, spleen, and lymph nodes. The gene discussed is FCER2; the disease is B-cell chronic lymphocytic leukemia.